Dinesh M.  Kumar net worth and biography

Dinesh Kumar Biography and Net Worth

Prior to joining Alignment Healthcare, Dr. Kumar held various leadership roles within HealthCare Partners Medical Group, a delegated full-risk medical group taking care of Medicare Advantage, commercial HMO and Medicaid patients. He spent his last two years at HealthCare Partners as a national leader of clinical transformation and helped execute on value-based care in various markets. In this role, he worked with internal clients as well as joint venture partners to set up medical management programs as well as create pathways to taking risk by building the needed infrastructure.

Dr. Kumar received his Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) from the University of Madras, Kilpauk Medical College & Hospital.

What is Dinesh M. Kumar's net worth?

The estimated net worth of Dinesh M. Kumar is at least $19.13 million as of March 29th, 2023. Dr. Kumar owns 1,088,651 shares of Alignment Healthcare stock worth more than $19,125,421 as of March 26th. This net worth evaluation does not reflect any other investments that Dr. Kumar may own. Learn More about Dinesh M. Kumar's net worth.

How do I contact Dinesh M. Kumar?

The corporate mailing address for Dr. Kumar and other Alignment Healthcare executives is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. Alignment Healthcare can also be reached via phone at 844-310-2247 and via email at alignmentir@westwicke.com. Learn More on Dinesh M. Kumar's contact information.

Has Dinesh M. Kumar been buying or selling shares of Alignment Healthcare?

Dinesh M. Kumar has not been actively trading shares of Alignment Healthcare in the last ninety days. Most recently, Dinesh M. Kumar sold 3,286 shares of the business's stock in a transaction on Wednesday, March 29th. The shares were sold at an average price of $6.11, for a transaction totalling $20,077.46. Following the completion of the sale, the insider now directly owns 1,088,651 shares of the company's stock, valued at $6,651,657.61. Learn More on Dinesh M. Kumar's trading history.

Who are Alignment Healthcare's active insiders?

Alignment Healthcare's insider roster includes Michael Foster (Insider), Robert Freeman (CFO), Christopher Joyce (Insider), John Kao (Founder & CEO), Hyong Kim (Insider), Joseph Konowiecki (Director), Dinesh Kumar (Insider), Jeffrey Margolis (Director), Dawn Maroney (Insider), and Robert Scavo (Insider). Learn More on Alignment Healthcare's active insiders.

Are insiders buying or selling shares of Alignment Healthcare?

In the last year, insiders at the sold shares 67 times. They sold a total of 2,867,170 shares worth more than $40,024,893.33. The most recent insider tranaction occured on March, 19th when insider Andreas P Wagner sold 7,632 shares worth more than $125,164.80. Insiders at Alignment Healthcare own 6.6% of the company. Learn More about insider trades at Alignment Healthcare.

Information on this page was last updated on 3/19/2025.

Dinesh M. Kumar Insider Trading History at Alignment Healthcare

Dinesh M. Kumar Buying and Selling Activity at Alignment Healthcare

This chart shows Dinesh M Kumar's buying and selling at Alignment Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Alignment Healthcare Company Overview

Alignment Healthcare logo
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More

Today's Range

Now: $17.57
Low: $17.29
High: $17.70

50 Day Range

MA: $15.06
Low: $13.16
High: $17.61

2 Week Range

Now: $17.57
Low: $4.46
High: $17.80

Volume

1,019,904 shs

Average Volume

1,431,991 shs

Market Capitalization

$3.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49